Teachers adds a new stake in PRA Health Sciences
PRA Health Sciences is a leading global contract research organization. PRA raised $306 million in its initial public offering in November last year.
Market overview for CROs suggest healthy growth for ICON
Market Overview Growth Drivers Appear Secular, Not Cyclical In general, CRO revenue growth is driven by three market-wide factors. First, as providers of clinical trials services, CROs are directly tied to R&D budgets among biopharmaceutical clients. Overall R&D budgets have been growing in the low-single digit range. Second, the percentage of clinical trials services performed […]
ICON could benefit from ongoing secular shift to outsourcing of clinical trials services
ICON plc (ICLR) is poised to benefit from an ongoing secular shift towards the outsourcing of clinical trials services. While this trend has already begun, it is likely only in the third or fourth inning, providing for several years of robust, predictable growth. In the more near-term, we believe that the Street is underestimating ICON’s margin […]